The National Agency for Food and Drug Administration and Control (NAFDAC) has appointed Cotecna Inspection Services (CIS) as a key agent under its Clean Report of Inspection and Analysis (CRIA) scheme to curb the influx of substandard and falsified medicines into the country
NAFDAC Director General, Prof. Mojisola Adeyeye, made this known while speaking at a hybrid technical meeting during the weekend
She said the agency was stepping up its regulatory efforts, especially targeting products from India and China, to ensure only safe and high-quality medicines were allowed into the country.
Adeyeye further revealed that NAFDAC had recently reviewed the performance of its CRIA agents—suspending one, renewing two, and appointing Cotecna to bolster oversight in India.
The CRIA scheme mandates thorough physical inspections and lab testing of all NAFDAC-regulated products before shipment to Nigeria.
CRIA agents ensure full compliance with NAFDAC’s labeling, packaging, and safety standards.
The move followed NAFDAC’s recent seizure and destruction of over N1 trillion worth of banned, expired, and counterfeit drugs across major drug markets in Idumota, Onitsha, and Aba.
News Edited by Favour Owonibi